Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy

OBJECTIVES: Small cell lung cancer (SCLC) patients of all stages are treated with etoposide and cisplatin or carboplatin with or without surgery or chest radiotherapy. Initial response rates are ≥70% however the majority of patients relapse and are resistant to additional therapies due to pan-resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Helfrich, Barbara A., Gao, Dexiang, Bunn, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916851/
https://www.ncbi.nlm.nih.gov/pubmed/29571994
http://dx.doi.org/10.1016/j.lungcan.2018.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916851/
https://www.ncbi.nlm.nih.gov/pubmed/29571994
http://dx.doi.org/10.1016/j.lungcan.2018.02.001

Ejemplares similares